#3 - Dendreon (DNDN)Recommended by: Hilary Kramer, editor of GameChangers
Return for August: +10% vs. -4% for the Dow Jones
In many ways, Dendreon (DNDN) is the poster child for game-changing biotech stocks. This company makes a prostate cancer treatment called Provenge, which is taken from the patient's cells and trains the body's immune system to fight the cancer. Provenge was approved by the FDA about three months ago to treat advanced prostate cancer, but the company is hopeful the technology will apply to other cancers as well in the future.
More From Investor Place
|Dividend Stocks to Grow Your Nest Egg|
|7 Expert Stock Picks for Every InvestorThere|
|GameChanger Stocks to Build Your Wealth|